Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
EPS for Viridian Therapeutics (VRDN)
EPS in 2023 (TTM): -$4.87
According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.87. In 2022 the company made an earnings per share (EPS) of -$4.03 an increase over its 2021 EPS that were of -$7.58.
EPS history for Viridian Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.87 | 20.84% |
| 2022 | -$4.03 | -46.83% |
| 2021 | -$7.58 | -73.94% |
| 2020 | -$29.09 | 44.73% |
| 2019 | -$20.10 | 22.94% |
| 2018 | -$16.35 | -27.33% |
| 2017 | -$22.50 | -91.47% |
| 2016 | -$263.70 | -19.17% |
| 2015 | -$326.25 | -75.48% |
| 2014 | -$1,331 | 582.47% |
| 2013 | -$194.96 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -55.24% | 🇺🇸 USA |